RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 ROCKET-AF: Rivaroxaban Prevents Stroke as Effectively as Warfarin, with Lower Bleeding Risk
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 12
OP 13
DO 10.1177/155989771010004
UL http://mdc.sagepub.com/content/10/10/12.abstract
AB Rivaroxaban was noninferior to warfarin in preventing all-cause stroke and noncentral nervous system embolism in patients with atrial fibrillation, according to new findings from the Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation [ROCKET-AF].